Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kausik K. Nanda

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Inorganic Chemistry|January 3, 1996
The First Oxovanadium(V)-Thiolate Complex, [VO(SCH(2)CH(2))(3)N]Kausik K. Nanda, Ekkehard Sinn, Anthony W. Addison
Journal of Pharmaceutical Sciences|August 8, 2020
Base-Mediated Oxidative Degradation of Secondary Amides Derived from p-Amino Phenol to Primary Amides in Drug MoleculesKausik K Nanda, Anthony Ginnetti, W Peter Wuelfing
Inorganic Chemistry|December 4, 1996
Helical Antiferromagnetic Copper(II) Chains with a Collagen Structural MotifKausik K. Nanda, Anthony W. Addison, Ekkehard Sinn, et al.
Inorganic Chemistry|April 16, 2002
Mononuclear and mixed-valence binuclear oxovanadium complexes with benzimidazole-derived chelating agentsShyamali Ghosh, Kausik K Nanda, Anthony W Addison, et al.
Journal of Pharmaceutical Sciences|November 6, 2018
Enrichment of Relevant Oxidative Degradation Products in Pharmaceuticals With Targeted Chemoselective OxidationKausik K Nanda, Olivier Mozziconacci, James Small, et al.
Journal of Neuroscience Methods|March 11, 2017
Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF-TrkA pathwayEric A Price, Alicja Krasowska-Zoladek, Kausik K Nanda, et al.
Journal of Pharmaceutical Sciences|February 5, 2017
Iron(III)-Mediated Oxidative Degradation on the Benzylic Carbon of Drug Molecules in the Absence of Initiating PeroxidesKausik K Nanda, William D Blincoe, Leonardo R Allain, et al.
Journal of Pharmaceutical Sciences|February 3, 2023
N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental ObservationsJustin Moser, Ian W Ashworth, Laurence Harris, et al.
Journal of Pharmaceutical Sciences|August 17, 2021
Inhibition of N-Nitrosamine Formation in Drug Products: A Model StudyKausik K Nanda, Steven Tignor, James Clancy, et al.
Inorganic Chemistry|April 10, 1996
Model Compounds for Iron Proteins. Structures and Magnetic, Spectroscopic, and Redox Properties of Fe(III)M(II) and [Co(III)Fe(III)](2)O Complexes with (&mgr;-Carboxylato)bis(&mgr;-phenoxo)dimetalate and (&mgr;-Oxo)diiron(III) CoresSujit K. Dutta, Rüdiger Werner, Ulrich Flörke, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Inorganic Chemistry|January 3, 1996
The First Oxovanadium(V)-Thiolate Complex, [VO(SCH(2)CH(2))(3)N]Kausik K. Nanda, Ekkehard Sinn, Anthony W. Addison
Journal of Pharmaceutical Sciences|August 8, 2020
Base-Mediated Oxidative Degradation of Secondary Amides Derived from p-Amino Phenol to Primary Amides in Drug MoleculesKausik K Nanda, Anthony Ginnetti, W Peter Wuelfing
Inorganic Chemistry|December 4, 1996
Helical Antiferromagnetic Copper(II) Chains with a Collagen Structural MotifKausik K. Nanda, Anthony W. Addison, Ekkehard Sinn, et al.
Inorganic Chemistry|April 16, 2002
Mononuclear and mixed-valence binuclear oxovanadium complexes with benzimidazole-derived chelating agentsShyamali Ghosh, Kausik K Nanda, Anthony W Addison, et al.
Journal of Pharmaceutical Sciences|November 6, 2018
Enrichment of Relevant Oxidative Degradation Products in Pharmaceuticals With Targeted Chemoselective OxidationKausik K Nanda, Olivier Mozziconacci, James Small, et al.
Journal of Neuroscience Methods|March 11, 2017
Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF-TrkA pathwayEric A Price, Alicja Krasowska-Zoladek, Kausik K Nanda, et al.
Journal of Pharmaceutical Sciences|February 5, 2017
Iron(III)-Mediated Oxidative Degradation on the Benzylic Carbon of Drug Molecules in the Absence of Initiating PeroxidesKausik K Nanda, William D Blincoe, Leonardo R Allain, et al.
Journal of Pharmaceutical Sciences|February 3, 2023
N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental ObservationsJustin Moser, Ian W Ashworth, Laurence Harris, et al.
Journal of Pharmaceutical Sciences|August 17, 2021
Inhibition of N-Nitrosamine Formation in Drug Products: A Model StudyKausik K Nanda, Steven Tignor, James Clancy, et al.
Inorganic Chemistry|April 10, 1996
Model Compounds for Iron Proteins. Structures and Magnetic, Spectroscopic, and Redox Properties of Fe(III)M(II) and [Co(III)Fe(III)](2)O Complexes with (&mgr;-Carboxylato)bis(&mgr;-phenoxo)dimetalate and (&mgr;-Oxo)diiron(III) CoresSujit K. Dutta, Rüdiger Werner, Ulrich Flörke, et al.
Pageof 3